journal article·2023-03-30Open access

Effects of Hyperlipidemia on Osseointegration of Dental Implants and Its Strategies

Haiyang Sun, Shuhuai Meng, Junyu Chen, Qianbing Wan

Abstract

Hyperlipidemia refers to the abnormal increase in plasma lipid level exceeding the normal range. At present, a large number of patients require dental implantation. However, hyperlipidemia affects bone metabolism, promotes bone loss, and inhibits the osseointegration of dental implants through the mutual regulation of adipocytes, osteoblasts, and osteoclasts. This review summarized the effects of hyperlipidemia on dental implants and addressed the potential strategies of dental implants to promote osseointegration in a hyperlipidemic environment and to improve the success rate of dental implants in patients with hyperlipidemia. We summarized topical drug delivery methods to solve the interference of hyperlipidemia in osseointegration, which were local drug injection, implant surface modification and bone-grafting material modification. Statins are the most effective drugs in the treatment of hyperlipidemia, and they also encourage bone formation. Statins have been used in these three methods and have been found to be positive in promoting osseointegration. Directly coating simvastatin on the rough surface of the implant can effectively promote osseointegration of the implant in a hyperlipidemic environment. However, the delivery method of this drug is not efficient. Recently, a variety of efficient methods of simvastatin delivery, such as hydrogels and nanoparticles, have been developed to boost bone formation, but few of them were applied to dental implants. Applicating these drug delivery systems using the three aforementioned ways, according to the mechanical and biological properties of materials, could be promising ways to promote osseointegration under hyperlipidemic conditions. However, more research is needed to confirm.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Oral microbiology and periodontitis research · Bone health and treatments · Dental Radiography and Imaging

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

State Key Laboratory of Oral Diseases, National Clinical Research Center for Oral Diseases, Department of Prosthodontics, West China Hospital of Stomatology, Sichuan University, Chengdu 610041, China

Funding

National Natural Science Foundation of China

References (100+)

Show source-provided references
2. Heart Disease and Stroke Statistics-2018 Update: A Report From the American Heart Association10.1161/CIR.0000000000000558 ↗
3. Osseointegrated implants in the treatment of the edentulous jaw. Experience from a 10-year period
4. Osseointegrated titanium implants. Requirements for ensuring a long-lasting, direct bone-to-implant anchorage in man10.3109/17453678108991776 ↗
5. Cholesterol-induced toxicity: An integrated view of the role of cholesterol in multiple diseases10.1016/j.cmet.2021.09.001 ↗
6. Osseointegration of titanium, titanium alloy and zirconia dental implants: Current knowledge and open questions10.1111/prd.12179 ↗
7. Nano-scale modification of titanium implant surfaces to enhance osseointegration10.1016/j.actbio.2019.05.045 ↗
8. The effect of hyperlipidemia on bone graft regeneration of peri-implantal created defects in rabbits10.1186/s40729-019-0170-x ↗
9. Hyperlipidemia Impairs Implant Osseointegration10.1111/clr.95_13509 ↗
10. The effects of hyperlipidemia on implant osseointegration in the mouse femur10.1563/AAID-JOI-D-13-00105 ↗
11. Effects of restraint stress and high-fat diet on osseointegration of titanium implants: An experimental study10.1590/1807-3107bor-2020.vol34.0008 ↗
12. The effects of high-fat diet on implant osseointegration: An experimental study10.5125/jkaoms.2016.42.4.187 ↗
13. Titanium dioxide nanoparticles increase plasma glucose via reactive oxygen species-induced insulin resistance in mice10.1002/jat.3150 ↗
14. Oxidized lipids formed non-enzymatically by reactive oxygen species10.1074/jbc.R800006200 ↗
15. Comparative effects of copper, iron, vanadium and titanium on low density lipoprotein oxidation in vitro
16. Hyperlipidemia Impairs Osseointegration via the ROS/Wnt/β-Catenin Pathway10.1177/0022034520983245 ↗
17. Yin, W., Li, Z., and Zhang, W. (2019). Modulation of Bone and Marrow Niche by Cholesterol. Nutrients, 11.10.3390/nu11061394 ↗
18. Hypercholesterolemia promotes an osteoporotic phenotype10.1016/j.ajpath.2012.05.034 ↗
19. Osteoporosis, jawbones and periodontal disease10.4317/medoral.18298 ↗
20. An 11-Year Retrospective Research Study of the Predictive Factors of Peri-Implantitis and Implant Failure: Analytic-Multicentric Study of 1279 Implants in Peru
21. Understanding the local actions of lipids in bone physiology10.1016/j.plipres.2015.06.002 ↗
22. Inhibition of adipogenesis by Wnt signaling10.1126/science.289.5481.950 ↗
23. Osteoporosis and obesity: Role of Wnt pathway in human and murine models10.5312/wjo.v5.i3.242 ↗
24. WNT signaling in bone homeostasis and disease: From human mutations to treatments10.1038/nm.3074 ↗
25. PPARγ agonists induce adipocyte differentiation by modulating the expression of Lipin-1, which acts as a PPARγ phosphatase10.1016/j.biocel.2016.10.018 ↗
26. Wnt and PPARgamma signaling in osteoblastogenesis and adipogenesis10.1038/nrrheum.2009.137 ↗
27. An integrative bioinformatics approach to decipher adipocyte-induced transdifferentiation of osteoblast10.1016/j.ygeno.2022.110422 ↗
29. Basis of bone metabolism around dental implants during osseointegration and peri-implant bone loss10.1002/jbm.a.36060 ↗
30. Muruganandan, S., Ionescu, A.M., and Sinal, C.J. (2020). At the Crossroads of the Adipocyte and Osteoclast Differentiation Programs: Future Therapeutic Perspectives. Int. J. Mol. Sci., 21.10.3390/ijms21072277 ↗
31. Molecular determinants for the polarization of macrophage and osteoclast10.1007/s00281-019-00754-3 ↗
32. Gai, Z., Wang, T., Visentin, M., Kullak-Ublick, G.A., Fu, X., and Wang, Z. (2019). Lipid Accumulation and Chronic Kidney Disease. Nutrients, 11.10.3390/nu11040722 ↗
33. Pathogenesis of sarcopenia and the relationship with fat mass: Descriptive review10.1002/jcsm.12901 ↗
34. Functional-morphologic aspects of changes of mucosal gingiva microcirculatory bed vessels in experimental gingivitis against the background of hypercholesterolemia
35. Association between periodontitis and hyperlipidemia: Cause or effect?10.1902/jop.1999.70.12.1429 ↗
36. Post-prandial endothelial dysfunction in hypertriglyceridemic subjects: Molecular mechanisms and gene expression studies10.1016/j.atherosclerosis.2006.09.015 ↗
37. Hyperlipidemia modifies innate immune responses to lipopolysaccharide via the TLR-NF-κB signaling pathway10.1007/s10753-013-9628-9 ↗
38. ABCG1 regulates mouse adipose tissue macrophage cholesterol levels and ratio of M1 to M2 cells in obesity and caloric restriction10.1194/jlr.M063354 ↗
39. Treatment of hyperlipidemia10.1056/NEJM197406062902306 ↗
40. Treatment of hyperlipidemia10.1146/annurev.me.41.020190.002351 ↗
41. Epidemiology and management of hyperlipidemia
42. Mechanisms of bone anabolism regulated by statins10.1042/BSR20110118 ↗
43. Potential mechanisms and applications of statins on osteogenesis: Current modalities, conflicts and future directions10.1016/j.jconrel.2015.07.022 ↗
44. Tooth loss, periodontitis, and statins in a population-based follow-up study10.1902/jop.2013.130456 ↗
45. Effectiveness of Simvastatin Versus Gemfibrozil for Primary Prevention of Cardiovascular Events: A Retrospective Cohort Study of 223,699 Primary Care Patients10.1007/s40261-022-01208-9 ↗
46. Comparison of statins for primary prevention of cardiovascular disease and persistent physical disability in older adults10.1007/s00228-021-03239-1 ↗
47. A Phase II Study of Preoperative Chemoradiotherapy with Capecitabine Plus Simvastatin in Patients with Locally Advanced Rectal Cancer10.4143/crt.2021.1527 ↗
48. Simvastatin rescues memory and granule cell maturation through the Wnt/β-catenin signaling pathway in a mouse model of Alzheimer’s disease10.1038/s41419-022-04784-y ↗
49. Enhanced angiogenesis and osteogenesis in critical bone defects by the controlled release of BMP-2 and VEGF: Implantation of electron beam melting-fabricated porous Ti6Al4V scaffolds incorporating growth factor-doped fibrin glue10.1088/1748-6041/10/3/035013 ↗
50. Statins augment vascular endothelial growth factor expression in osteoblastic cells via inhibition of protein prenylation10.1210/en.2002-220682 ↗
51. Effect of simvastatin on the osteogenetic behavior of alveolar osteoblasts and periodontal ligament cells10.1007/s13577-011-0028-x ↗
52. Simvastatin promotes osteogenesis around titanium implants10.1046/j.1600-0501.2003.01015.x ↗
53. Simvastatin enhances bone formation around titanium implants in rat tibiae10.1111/j.1365-2842.2009.02011.x ↗
54. Effects of Simvastatin on bone healing around titanium implants in osteoporotic rats10.1111/j.1600-0501.2008.01630.x ↗
55. Simvastatin reverses the harmful effects of high fat diet on titanium rod osseointegration in ovariectomized rats10.1007/s00774-021-01243-0 ↗
56. Single-dose local simvastatin injection improves implant fixation via increased angiogenesis and bone formation in an ovariectomized rat model10.12659/MSM.892247 ↗
57. Topical application of statin affects bone healing around implants10.1111/j.1600-0501.2007.01508.x ↗
58. Local application of fluvastatin improves peri-implant bone quantity and mechanical properties: A rodent study10.1016/j.actbio.2009.10.045 ↗
59. The effect of a single remote injection of statin-impregnated poly (lactic-co-glycolic acid) microspheres on osteogenesis around titanium implants in rat tibia10.1016/j.biomaterials.2010.01.016 ↗
60. Sdccag3 Promotes Implant Osseointegration during Experimental Hyperlipidemia10.1177/0022034520916400 ↗
61. MicroRNA-29a-3p enhances dental implant osseointegration of hyperlipidemic rats via suppressing dishevelled 2 and frizzled 410.1186/s13578-018-0254-y ↗
62. Research on implants and osseointegration10.1111/prd.12254 ↗
63. Surface treatments of titanium dental implants for rapid osseointegration10.1016/j.dental.2006.06.025 ↗
64. Accelerated and enhanced bone formation on novel simvastatin-loaded porous titanium oxide surfaces10.1111/cid.12045 ↗
65. Simvastatin-activated implant surface promotes osteoblast differentiation in vitro10.1177/0885328213486364 ↗
66. Bone responses to simvastatin-loaded porous implant surfaces in an ovariectomized model
67. Osteogenic effects of simvastatin-loaded mesoporous titania thin films10.1088/1748-605X/aa95f1 ↗
68. In vitro and in vivo evaluation of the osteogenic ability of implant surfaces with a local delivery of simvastatin10.11607/jomi.3147 ↗
69. Enhanced in vitro osteoblast differentiation on TiO2 scaffold coated with alginate hydrogel containing simvastatin10.1177/2041731413515670 ↗
70. Influence of simvastatin-loaded implants on osseointegration in an ovariectomized animal model10.1155/2015/831504 ↗
71. Topical applications of vitamin D on implant surface for bone-to-implant contact enhance: A pilot study in dogs part II10.1111/clr.12707 ↗
72. Vitamin D and bone physiology: Demonstration of vitamin D deficiency in an implant osseointegration rat model10.1111/j.1532-849X.2009.00446.x ↗
73. Promoting effect of 1,25(OH)2 vitamin D3 in osteogenic differentiation from induced pluripotent stem cells to osteocyte-like cells10.1098/rsob.140201 ↗
74. 1-Alpha, 25-dihydroxy vitamin D3 inhibits osteoclastogenesis through IFN-beta-dependent NFATc1 suppression10.1007/s00774-009-0084-4 ↗
75. Alfacalcidol inhibits bone resorption and stimulates formation in an ovariectomized rat model of osteoporosis: Distinct actions from estrogen10.1359/jbmr.2000.15.4.770 ↗
76. A novel synthetic vitamin D analogue, 2 beta-(3-hydroxypropoxy)1 alpha, 25-dihydroxyvitamin D3 (ED-71), increases bone mass by stimulating the bone formation in normal and ovariectomized rats10.1007/BF00296065 ↗
77. DHCR7: A vital enzyme switch between cholesterol and vitamin D production10.1016/j.plipres.2016.09.003 ↗
78. Vitamin D and Cardiovascular Disease: Controversy Unresolved10.1016/j.jacc.2017.05.031 ↗
79. Evaluation of simvastatin grafting around immediate dental implants in dogs10.1097/ID.0000000000000051 ↗
80. Wang, C.Z., Wang, Y.H., Lin, C.W., Lee, T.C., Fu, Y.C., Ho, M.L., and Wang, C.K. (2018). Combination of a Bioceramic Scaffold and Simvastatin Nanoparticles as a Synthetic Alternative to Autologous Bone Grafting. Int. J. Mol. Sci, 19.10.3390/ijms19124099 ↗
81. Effects of simvastatin gel on bone regeneration in alveolar defects in miniature pigs
82. Simvastatin-Incorporated Drug Delivery Systems for Bone Regeneration10.1021/acsbiomaterials.1c00462 ↗
83. In vitro evaluation of simvastatin acid (SVA) coated beta-tricalcium phosphate (β-TCP) particle on bone tissue regeneration10.1007/s13233-012-0097-z ↗
84. Controlled release of simvastatin-loaded thermo-sensitive PLGA-PEG-PLGA hydrogel for bone tissue regeneration: In vitro and in vivo characteristics10.1002/jbm.a.35499 ↗
85. Formulation of simvastatin chitosan nanoparticles for controlled delivery in bone regeneration: Optimization using Box-Behnken design, stability and in vivo study10.1016/j.ijpharm.2020.119038 ↗
86. 3D printed poly(ε-caprolactone) scaffolds function with simvastatin-loaded poly(lactic-co-glycolic acid) microspheres to repair load-bearing segmental bone defects
87. Poly(l-Lactic Acid)/Gelatin Fibrous Scaffold Loaded with Simvastatin/Beta-Cyclodextrin-Modified Hydroxyapatite Inclusion Complex for Bone Tissue Regeneration10.1002/mabi.201500450 ↗
88. Controlled Release of Simvastatin from In situ Forming Hydrogel Triggers Bone Formation in MC3T3-E1 Cells10.1208/s12248-012-9442-6 ↗
89. Sustained release of water-insoluble simvastatin from biodegradable hydrogel augments bone regeneration10.1016/j.jconrel.2009.12.027 ↗
90. Osteogenic potential of simvastatin loaded gelatin-nanofibrillar cellulose-β tricalcium phosphate hydrogel scaffold in critical-sized rat calvarial defect10.1016/j.eurpolymj.2015.10.022 ↗
91. Photo-cured hyaluronic acid-based hydrogels containing simvastatin as a bone tissue regeneration scaffold10.1016/j.biomaterials.2011.07.045 ↗
92. Co-delivery of simvastatin and demineralized bone matrix hierarchically from nanosheet-based supramolecular hydrogels for osteogenesis10.1039/D1TB01256H ↗
93. Hierarchically porous calcium-silicon nanosphere-enabled co-delivery of microRNA-210 and simvastatin for bone regeneration10.1039/D1TB00063B ↗
94. β-tricalcium phosphate for bone substitution: Synthesis and properties10.1016/j.actbio.2020.06.022 ↗
95. Surface treatments on titanium implants via nanostructured ceria for antibacterial and anti-inflammatory capabilities10.1016/j.actbio.2019.06.023 ↗
96. Titania nanotube array supported nanoceria with redox cycling stability ameliorates oxidative stress-inhibited osteogenesis10.1016/j.cej.2021.128913 ↗
97. The effects of Ce on the proliferation, osteogenic differentiation and mineralization function of MC3T3-E1 cells in vitro10.1007/s12011-012-9423-8 ↗
98. TGF-β/BMP signaling pathway is involved in cerium-promoted osteogenic differentiation of mesenchymal stem cells10.1002/jcb.24451 ↗
99. Valence State Manipulation of Cerium Oxide Nanoparticles on a Titanium Surface for Modulating Cell Fate and Bone Formation10.1002/advs.201700678 ↗
100. Mesoporous silica coated CeO(2) nanozymes with combined lipid-lowering and antioxidant activity induce long-term improvement of the metabolic profile in obese Zucker rats10.1039/D1NR00790D ↗